CD8A and lung carcinoma: Let-7b post-transcriptionally suppressed PD-L1 and PD-1 expression in the tumor microenvironment, and let-7b treatment reduced PD-1 expression in CD8+ T cells, decreased PD-L1 expression in lung cancer cells, and enhanced the function of antitumor CD8+ T cells [150].